Novo's blockbuster diabetes drug Ozempic belongs to a class of drugs known as GLP-1 receptor agonists and has the same active ...

Researchers from NYU Langone Health found that Americans older than 55 have a 42% risk of developing dementia — nearly twice ...

Data from nations around the world can be used to develop strategies for dementia prevention, treatment, and care, according to “Multidisciplinary Perspectives on Dementia and Related Population ...

Access to the new Alzheimer's drugs is limited by strict eligibility criteria, long wait times, and a lack of infusion ...

Taking too long to enter the phase of sleep in which we dream may be an early sign of Alzheimer's disease. This is the ...

There are two kinds of risk factors for dementia: non-modifiable and modifiable. Non-modifiable risk factors are ones that cannot be changed or eliminated, like aging, family history and genetics.

The type of work that requires this type of processing in the brain might help guard against Alzheimer's disease.

A study published in the British medical journal suggests that taxi and ambulance drivers may be at less risk from ...

Yet despite decades of research, no treatment has been created that arrests Alzheimer’s cognitive deterioration, let alone ...

Arctic therapeutics raises funding from EIC Fund, Kaldbakur, and Sanos Group to advance its dementia treatment, AT-001, and acne drug, AT-004. The company aims to transform the treatment landscape for ...